These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1674555)

  • 21. Opium consumption in men and diabetes mellitus in women are the most important risk factors of premature coronary artery disease in Iran.
    Sadeghian S; Graili P; Salarifar M; Karimi AA; Darvish S; Abbasi SH
    Int J Cardiol; 2010 May; 141(1):116-8. PubMed ID: 19346018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease.
    Duman BS; Türkoğlu C; Akpinar B; Güden M; Vertii A; Cağatay P; Günay D; Sevim Büyükdevrim A
    Ann Hum Biol; 2005; 32(5):620-9. PubMed ID: 16316917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population.
    Berdeli A; Sekuri C; Sirri Cam F; Ercan E; Sagcan A; Tengiz I; Eser E; Akin M
    Clin Chim Acta; 2005 Jan; 351(1-2):87-94. PubMed ID: 15563875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restriction fragment length polymorphism of the human apo B and apo AII gene regions among type II diabetics.
    Ghusn H; Arem R; Frazier M; Chamakhi S; Ezzaouia G; Chan L
    Res Commun Mol Pathol Pharmacol; 1996 Jul; 93(1):25-32. PubMed ID: 8865367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk for gestational diabetes mellitus associated with insulin receptor and insulin-like growth factor II restriction fragment length polymorphisms.
    Ober C; Xiang KS; Thisted RA; Indovina KA; Wason CJ; Dooley S
    Genet Epidemiol; 1989; 6(5):559-69. PubMed ID: 2574127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association among oxidized LDL levels, MnSOD, apolipoprotein E polymorphisms, and cardiovascular risk factors in a south Brazilian region population.
    Gottlieb MG; Schwanke CH; Santos AF; Jobim PF; Müssel DP; da Cruz IB
    Genet Mol Res; 2005 Dec; 4(4):691-703. PubMed ID: 16475114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between apolipoprotein E polymorphism and coronary artery disease in the Kermanshah population in Iran.
    Kharrazi H; Vaisi Raygani A; Sabokroh AR; Pourmotabbed T
    Clin Biochem; 2006 Jun; 39(6):613-6. PubMed ID: 16545358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human apolipoprotein genes.
    Scott J
    Oxf Surv Eukaryot Genes; 1987; 4():168-97. PubMed ID: 2908023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients.
    Gazzaruso C; Bruno R; Pujia A; De Amici E; Fratino P; Solerte SB; Garzaniti A
    Int J Cardiol; 2006 Apr; 108(3):354-8. PubMed ID: 15961173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of endothelial nitric oxide synthase gene polymorphisms (-786T>C, 4a4b, 894G>T) in Korean patients with coronary artery disease.
    Kim IJ; Bae J; Lim SW; Cha DH; Cho HJ; Kim S; Yang DH; Hwang SG; Oh D; Kim NK
    Thromb Res; 2007; 119(5):579-85. PubMed ID: 16842840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease.
    Falcone C; Geroldi D; Buzzi MP; Emanuele E; Yilmaz Y; Fontana JM; Vignali L; Boiocchi C; Sbarsi I; Cuccia M
    Arch Med Res; 2008 Apr; 39(3):320-5. PubMed ID: 18279705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple RFLPs at the human apolipoprotein D (APOD) locus.
    Drayna D; Scott JD; Lawn R
    Nucleic Acids Res; 1987 Nov; 15(22):9617. PubMed ID: 2891117
    [No Abstract]   [Full Text] [Related]  

  • 33. [Progress in the study of lipoprotein metabolism and atherosclerosis: progress in the molecular genetic study of apolipoproteins and hyperlipidemia].
    Itoh H; Mabuchi H; Takeda R
    Nihon Rinsho; 1988 Mar; 46(3):644-51. PubMed ID: 2900342
    [No Abstract]   [Full Text] [Related]  

  • 34. Disease associations. Chance, artifact, or susceptibility genes?
    Cox NJ; Bell GI
    Diabetes; 1989 Aug; 38(8):947-50. PubMed ID: 2568956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Optimal medical therapy in diabetic patients with coronary artery disease].
    Ogita M; Daida H
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():311-8. PubMed ID: 27266109
    [No Abstract]   [Full Text] [Related]  

  • 36. [Etiology and pathology of coronary artery disease in diabetes patients].
    Tachibana K; Sakata Y
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():302-5. PubMed ID: 27266107
    [No Abstract]   [Full Text] [Related]  

  • 37. [Metabolic disease and molecular biology].
    Kasuga M
    Nihon Naika Gakkai Zasshi; 1992 Sep; 81(9):1367-70. PubMed ID: 1360485
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic regulation of apolipoproteins.
    Breslow JL
    Am Heart J; 1987 Feb; 113(2 Pt 2):422-7. PubMed ID: 2880491
    [No Abstract]   [Full Text] [Related]  

  • 39. Blood lipids, lipid-related measures, and the risk of atherosclerotic cardiovascular disease.
    Wallace RB; Anderson RA
    Epidemiol Rev; 1987; 9():95-119. PubMed ID: 3315721
    [No Abstract]   [Full Text] [Related]  

  • 40. [Coronary insufficiency in diabetes mellitus].
    BOULIN R; KAUFMANN H
    Bull Med; 1952 Jun; 66(12):273-8. PubMed ID: 12997929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.